These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

383 related articles for article (PubMed ID: 17597792)

  • 1. Modulating mtDNA heteroplasmy by mitochondria-targeted restriction endonucleases in a 'differential multiple cleavage-site' model.
    Bacman SR; Williams SL; Hernandez D; Moraes CT
    Gene Ther; 2007 Sep; 14(18):1309-18. PubMed ID: 17597792
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rapid directional shift of mitochondrial DNA heteroplasmy in animal tissues by a mitochondrially targeted restriction endonuclease.
    Bayona-Bafaluy MP; Blits B; Battersby BJ; Shoubridge EA; Moraes CT
    Proc Natl Acad Sci U S A; 2005 Oct; 102(40):14392-7. PubMed ID: 16179392
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Organ-specific shifts in mtDNA heteroplasmy following systemic delivery of a mitochondria-targeted restriction endonuclease.
    Bacman SR; Williams SL; Garcia S; Moraes CT
    Gene Ther; 2010 Jun; 17(6):713-20. PubMed ID: 20220783
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Manipulation of mtDNA heteroplasmy in all striated muscles of newborn mice by AAV9-mediated delivery of a mitochondria-targeted restriction endonuclease.
    Bacman SR; Williams SL; Duan D; Moraes CT
    Gene Ther; 2012 Nov; 19(11):1101-6. PubMed ID: 22130448
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mitochondrial targeted meganuclease as a platform to eliminate mutant mtDNA in vivo.
    Zekonyte U; Bacman SR; Smith J; Shoop W; Pereira CV; Tomberlin G; Stewart J; Jantz D; Moraes CT
    Nat Commun; 2021 May; 12(1):3210. PubMed ID: 34050192
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selective elimination of mitochondrial mutations in the germline by genome editing.
    Reddy P; Ocampo A; Suzuki K; Luo J; Bacman SR; Williams SL; Sugawara A; Okamura D; Tsunekawa Y; Wu J; Lam D; Xiong X; Montserrat N; Esteban CR; Liu GH; Sancho-Martinez I; Manau D; Civico S; Cardellach F; Del Mar O'Callaghan M; Campistol J; Zhao H; Campistol JM; Moraes CT; Izpisua Belmonte JC
    Cell; 2015 Apr; 161(3):459-469. PubMed ID: 25910206
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Real-Time PCR Quantification of Heteroplasmy in a Mouse Model with Mitochondrial DNA of C57BL/6 and NZB/BINJ Strains.
    Machado TS; Macabelli CH; Sangalli JR; Rodrigues TB; Smith LC; Meirelles FV; Chiaratti MR
    PLoS One; 2015; 10(8):e0133650. PubMed ID: 26274500
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Manipulating mitochondrial DNA heteroplasmy by a mitochondrially targeted restriction endonuclease.
    Srivastava S; Moraes CT
    Hum Mol Genet; 2001 Dec; 10(26):3093-9. PubMed ID: 11751691
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modulating Mitochondrial DNA Heteroplasmy with Mitochondrially Targeted Endonucleases.
    Mikhailov N; Hämäläinen RH
    Ann Biomed Eng; 2024 Sep; 52(9):2627-2640. PubMed ID: 36001180
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The use of mitochondria-targeted endonucleases to manipulate mtDNA.
    Bacman SR; Williams SL; Pinto M; Moraes CT
    Methods Enzymol; 2014; 547():373-97. PubMed ID: 25416366
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gene therapy for mitochondrial disease by delivering restriction endonuclease SmaI into mitochondria.
    Tanaka M; Borgeld HJ; Zhang J; Muramatsu S; Gong JS; Yoneda M; Maruyama W; Naoi M; Ibi T; Sahashi K; Shamoto M; Fuku N; Kurata M; Yamada Y; Nishizawa K; Akao Y; Ohishi N; Miyabayashi S; Umemoto H; Muramatsu T; Furukawa K; Kikuchi A; Nakano I; Ozawa K; Yagi K
    J Biomed Sci; 2002; 9(6 Pt 1):534-41. PubMed ID: 12372991
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A systematic analysis of the suitability of preimplantation genetic diagnosis for mitochondrial diseases in a heteroplasmic mitochondrial mouse model.
    Neupane J; Vandewoestyne M; Heindryckx B; Ghimire S; Lu Y; Qian C; Lierman S; Van Coster R; Gerris J; Deroo T; Deforce D; De Sutter P
    Hum Reprod; 2014 Apr; 29(4):852-9. PubMed ID: 24524987
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Current strategies towards therapeutic manipulation of mtDNA heteroplasmy.
    Pereira CV; Moraes CT
    Front Biosci (Landmark Ed); 2017 Jan; 22(6):991-1010. PubMed ID: 27814659
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tissue-specific modulation of mitochondrial DNA segregation by a defect in mitochondrial division.
    Jokinen R; Marttinen P; Stewart JB; Neil Dear T; Battersby BJ
    Hum Mol Genet; 2016 Feb; 25(4):706-14. PubMed ID: 26681804
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of chemically modified oligonucleotides targeting a pathogenic mutation in human mitochondrial DNA.
    Tonin Y; Heckel AM; Dovydenko I; Meschaninova M; Comte C; Venyaminova A; Pyshnyi D; Tarassov I; Entelis N
    Biochimie; 2014 May; 100():192-9. PubMed ID: 23994754
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selective elimination of mutant mitochondrial genomes as therapeutic strategy for the treatment of NARP and MILS syndromes.
    Alexeyev MF; Venediktova N; Pastukh V; Shokolenko I; Bonilla G; Wilson GL
    Gene Ther; 2008 Apr; 15(7):516-23. PubMed ID: 18256697
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Altering the balance between healthy and mutated mitochondrial DNA.
    Smith PM; Lightowlers RN
    J Inherit Metab Dis; 2011 Apr; 34(2):309-13. PubMed ID: 20506041
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mitochondrial DNA heteroplasmy in disease and targeted nuclease-based therapeutic approaches.
    Nissanka N; Moraes CT
    EMBO Rep; 2020 Mar; 21(3):e49612. PubMed ID: 32073748
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Deletions of muscle mitochondrial DNA in patients with mitochondrial myopathies.
    Holt IJ; Harding AE; Morgan-Hughes JA
    Nature; 1988 Feb; 331(6158):717-9. PubMed ID: 2830540
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modulating mitochondrial quality in disease transmission: towards enabling mitochondrial DNA disease carriers to have healthy children.
    Diot A; Dombi E; Lodge T; Liao C; Morten K; Carver J; Wells D; Child T; Johnston IG; Williams S; Poulton J
    Biochem Soc Trans; 2016 Aug; 44(4):1091-100. PubMed ID: 27528757
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.